DNER and precursor B-cell acute lymphoblastic leukemia: BET inhibition also been shown to be efficient against primary childhood B-ALL by decreasing c-Myc protein stability, suppressing progression at DNA replication forks, and sensitizing primary B-ALL towards dexamethasone in vitro and in vivo (18).